On Tuesday, Haemonetics Corp (NYSE: HAE) opened lower -3.79% from the last session, before settling in for the closing price of $88.17. Price fluctuations for HAE have ranged from $70.25 to $97.97 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 6.80% over the past five years. Company’s average yearly earnings per share was noted 15.95% at the time writing. With a float of $49.68 million, this company’s outstanding shares have now reached $50.79 million.
Let’s look at the performance matrix of the company that is accounted for 3657 employees. In terms of profitability, gross margin is 51.7%, operating margin of 14.19%, and the pretax margin is 11.67%.
Haemonetics Corp (HAE) Insider Updates
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Haemonetics Corp is 1.09%, while institutional ownership is 112.03%. The most recent insider transaction that took place on Nov 11 ’24, was worth 565,692. Before that another transaction happened on Jul 26 ’24, when Company’s President, Global Hospital sold 4,312 for $91.15, making the entire transaction worth $393,039. This insider now owns 18,196 shares in total.
Haemonetics Corp (HAE) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 15.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.05% during the next five years compared to 17.09% growth over the previous five years of trading.
Haemonetics Corp (NYSE: HAE) Trading Performance Indicators
Check out the current performance indicators for Haemonetics Corp (HAE). In the past quarter, the stock posted a quick ratio of 2.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.13. Likewise, its price to free cash flow for the trailing twelve months is 112.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.41, a number that is poised to hit 1.17 in the next quarter and is forecasted to reach 5.35 in one year’s time.
Technical Analysis of Haemonetics Corp (HAE)
Haemonetics Corp (NYSE: HAE) saw its 5-day average volume 0.67 million, a positive change from its year-to-date volume of 0.56 million. As of the previous 9 days, the stock’s Stochastic %D was 49.53%. Additionally, its Average True Range was 2.69.
During the past 100 days, Haemonetics Corp’s (HAE) raw stochastic average was set at 58.94%, which indicates a significant increase from 58.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.82% in the past 14 days, which was higher than the 36.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $78.07, while its 200-day Moving Average is $81.89. Nevertheless, the first resistance level for the watch stands at $86.62 in the near term. At $88.41, the stock is likely to face the second major resistance level. The third major resistance level sits at $89.34. If the price goes on to break the first support level at $83.90, it is likely to go to the next support level at $82.97. Assuming the price breaks the second support level, the third support level stands at $81.18.
Haemonetics Corp (NYSE: HAE) Key Stats
There are currently 50,224K shares outstanding in the company with a market cap of 4.26 billion. Presently, the company’s annual sales total 1,309 M according to its annual income of 117,560 K. Last quarter, the company’s sales amounted to 345,510 K and its income totaled 33,830 K.
